The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma

BACKGROUND: Glioblastoma (GBM) is a fatal brain tumor, lacking effective treatment. Epidermal growth factor receptor (EGFR) is recognized as an attractive target for GBM treatment. However, GBMs have very poor responses to the first- and second-generation EGFR inhibitors. The third-generation EGFR-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuejiao, Chen, Xiangyu, Shi, Lin, Shan, Qianqian, Cao, Qiyu, Yue, Chenglong, Li, Huan, Li, Shengsheng, Wang, Jie, Gao, Shangfeng, Niu, Mingshan, Yu, Rutong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533774/
https://www.ncbi.nlm.nih.gov/pubmed/31122294
http://dx.doi.org/10.1186/s13046-019-1235-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533774/
https://www.ncbi.nlm.nih.gov/pubmed/31122294
http://dx.doi.org/10.1186/s13046-019-1235-7

Ejemplares similares